... pharmaceutical company, focuses on the development and marketing of products for the treatment of dermatological, aesthetic, and podiatric conditions in the United States and Canada. Its products address various conditions, including acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, eczema, skin and skin -structure infections, seborrheic dermatitis, and cosmesis. The company s product portfolio comprises DYNACIN, an oral adjunctive treatment for moderate to severe acne; LOPROX, for the treatment of fungal and yeast infections; OMNICEF, a patented oral cephalosporin for skin and skin -structure infections; PLEXION, for the treatment of rosacea and acne -related conditions; RESTYLANE, an injectable gel for the treatment of fine lines and wrinkles, shaping facial contours, and correcting deep facial folds; TRIAZ for the treatment of acne; and VANOS for the treatment of plaque type psoriasis in adult patients....
|
